KEWAUNEE SCIENTIFIC CP (KEQU) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:KEQU • US4928541048

40.51 USD
+0.32 (+0.8%)
Last: Feb 3, 2026, 08:28 PM
Fundamental Rating

5

Taking everything into account, KEQU scores 5 out of 10 in our fundamental rating. KEQU was compared to 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of KEQU get a neutral evaluation. Nothing too spectacular is happening here. KEQU has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • KEQU had positive earnings in the past year.
  • KEQU had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.
  • In multiple years KEQU reported negative operating cash flow during the last 5 years.
KEQU Yearly Net Income VS EBIT VS OCF VS FCFKEQU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M

1.2 Ratios

  • KEQU has a better Return On Assets (6.21%) than 86.02% of its industry peers.
  • KEQU has a Return On Equity of 16.81%. This is amongst the best in the industry. KEQU outperforms 92.47% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 10.67%, KEQU belongs to the top of the industry, outperforming 90.86% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for KEQU is in line with the industry average of 8.80%.
  • The 3 year average ROIC (9.90%) for KEQU is below the current ROIC(10.67%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.21%
ROE 16.81%
ROIC 10.67%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
KEQU Yearly ROA, ROE, ROICKEQU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 4.11%, KEQU is in the better half of the industry, outperforming 76.34% of the companies in the same industry.
  • With a decent Operating Margin value of 6.89%, KEQU is doing good in the industry, outperforming 72.58% of the companies in the same industry.
  • The Gross Margin of KEQU (29.09%) is worse than 75.81% of its industry peers.
  • In the last couple of years the Gross Margin of KEQU has grown nicely.
Industry RankSector Rank
OM 6.89%
PM (TTM) 4.11%
GM 29.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
KEQU Yearly Profit, Operating, Gross MarginsKEQU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KEQU is creating some value.
  • The number of shares outstanding for KEQU remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, KEQU has more shares outstanding
  • KEQU has a worse debt/assets ratio than last year.
KEQU Yearly Shares OutstandingKEQU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
KEQU Yearly Total Debt VS Total AssetsKEQU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 3.35 indicates that KEQU is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.35, KEQU is in the better half of the industry, outperforming 70.97% of the companies in the same industry.
  • The Debt to FCF ratio of KEQU is 12.32, which is on the high side as it means it would take KEQU, 12.32 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 12.32, KEQU is doing good in the industry, outperforming 72.04% of the companies in the same industry.
  • A Debt/Equity ratio of 0.85 indicates that KEQU is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.85, KEQU is not doing good in the industry: 73.12% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 12.32
Altman-Z 3.35
ROIC/WACC1.05
WACC10.14%
KEQU Yearly LT Debt VS Equity VS FCFKEQU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 2.48 indicates that KEQU has no problem at all paying its short term obligations.
  • KEQU has a Current ratio of 2.48. This is comparable to the rest of the industry: KEQU outperforms 53.23% of its industry peers.
  • KEQU has a Quick Ratio of 1.71. This is a normal value and indicates that KEQU is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of KEQU (1.71) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 1.71
KEQU Yearly Current Assets VS Current LiabilitesKEQU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

  • KEQU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.55%.
  • KEQU shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.02%.
  • Measured over the past years, KEQU shows a quite strong growth in Revenue. The Revenue has been growing by 10.27% on average per year.
EPS 1Y (TTM)-37.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.15%
Revenue 1Y (TTM)43.02%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.76%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KEQU Yearly Revenue VS EstimatesKEQU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
KEQU Yearly EPS VS EstimatesKEQU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.5 1 1.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.02, the valuation of KEQU can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 96.77% of the companies listed in the same industry.
  • KEQU is valuated cheaply when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.02
Fwd PE N/A
KEQU Price Earnings VS Forward Price EarningsKEQU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 97.31% of the companies in the same industry are more expensive than KEQU, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, KEQU is valued cheaply inside the industry as 86.02% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 22.7
EV/EBITDA 6.39
KEQU Per share dataKEQU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • KEQU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for KEQU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (2/3/2026, 8:28:11 PM)

40.51

+0.32 (+0.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)12-10
Earnings (Next)03-10
Inst Owners41.13%
Inst Owner Change-0.53%
Ins Owners15.89%
Ins Owner Change-3.83%
Market Cap116.26M
Revenue(TTM)285.51M
Net Income(TTM)11.74M
Analysts82.86
Price TargetN/A
Short Float %1.25%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.02
Fwd PE N/A
P/S 0.41
P/FCF 22.7
P/OCF 13.41
P/B 1.66
P/tB 2.88
EV/EBITDA 6.39
EPS(TTM)5.05
EY12.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.78
FCFY4.4%
OCF(TTM)3.02
OCFY7.45%
SpS99.48
BVpS24.34
TBVpS14.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number52.59
Profitability
Industry RankSector Rank
ROA 6.21%
ROE 16.81%
ROCE 13.73%
ROIC 10.67%
ROICexc 11.69%
ROICexgc 15.07%
OM 6.89%
PM (TTM) 4.11%
GM 29.09%
FCFM 1.79%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.51
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 12.32
Debt/EBITDA 2.29
Cap/Depr 56.58%
Cap/Sales 1.24%
Interest Coverage 250
Cash Conversion 33.42%
Profit Quality 43.61%
Current Ratio 2.48
Quick Ratio 1.71
Altman-Z 3.35
F-Score4
WACC10.14%
ROIC/WACC1.05
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.02%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1290.93%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y51.55%
OCF growth 3YN/A
OCF growth 5Y28.86%

KEWAUNEE SCIENTIFIC CP / KEQU FAQ

What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a fundamental rating of 5 / 10 to KEQU.


What is the valuation status of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.


How profitable is KEWAUNEE SCIENTIFIC CP (KEQU) stock?

KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.


How financially healthy is KEWAUNEE SCIENTIFIC CP?

The financial health rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 5 / 10.


Is the dividend of KEWAUNEE SCIENTIFIC CP sustainable?

The dividend rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 0 / 10 and the dividend payout ratio is 0%.